Notes / Company

Novelix Pharmaceuticals Ltd.

TRIMURTHI BSE 536565 ISIN INE314I01036 Trading

Fundamentals

Market cap: ₹115 cr
P/E: 63.05×
ROE: 0.48%
Debt / equity: 0.00
52-week range: 27.94 — 70.16

The timeline — 1 note on Novelix Pharmaceuticals Ltd.

May 2026

25 May 26 · 8:06 PM IST Brief

Brief · Micro cap

Novelix Pharmaceuticals eyes another capital raise via preferential issue

The nano-cap company plans to discuss a fresh preferential issue of securities at its upcoming board meeting, following two capital raises earlier this year.

Verify on exchange BSE filings for TRIMURTHI NSE filings for TRIMURTHI